CZ ATC L01EX03 · updated 2 Nov 2026
Pazopanib shortage in Czechia
Is there a Pazopanib shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Pazopanib products are reported short in Czechia, the first since 29 Jul 2026. The company estimate for the return is 20 Nov 2026 (latest 10 Dec 2026). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | PYZYPI 200MG 200MG TBL FLM 30 | STADA Arzneimittel AG, Bad Vilbel | 29 Jul 2026 | 10 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | PAZOPANIB ACCORD 200MG 200MG TBL FLM 30 | Accord (Intas) | 26 Oct 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.